MorphoSys's Licensee Janssen Submits Biologics License Application to U.S. FDA of TremfyaR Guselkumab for Treatment of Adults with Active Psoriatic Arthritis news with additional features

DGAPNews MorphoSys AG Key words Regulatory Admission 16.09.2019 1357 The issuer is solely responsible for the content of this announcement.PlaneggMunich Germany September 16 2019MorphoSys's Licensee Janssen Submits Biologics License Application to U.S. F...